Trans Genic Inc. (2342.T)
JPY 181.0
(0.56%)
JPY 181.0
(0.56%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 2.24 Billion JPY | 12.75% |
| 2022 | 1.99 Billion JPY | -48.0% |
| 2021 | 3.83 Billion JPY | 38.13% |
| 2020 | 2.77 Billion JPY | 56.1% |
| 2019 | 1.77 Billion JPY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 501 Million JPY | -14.46% |
| 2023 Q2 | 525.71 Million JPY | -17.77% |
| 2023 FY | 2.24 Billion JPY | 12.75% |
| 2023 Q3 | 498.46 Million JPY | -5.18% |
| 2023 Q1 | 639.36 Million JPY | 79.04% |
| 2023 Q4 | 585.71 Million JPY | 17.5% |
| 2022 Q3 | 526.22 Million JPY | -19.95% |
| 2022 FY | 1.99 Billion JPY | -48.0% |
| 2022 Q4 | 357.1 Million JPY | -32.14% |
| 2022 Q2 | 657.38 Million JPY | 0.0% |
| 2021 FY | 3.83 Billion JPY | 38.13% |
| 2020 FY | 2.77 Billion JPY | 56.1% |
| 2019 FY | 1.77 Billion JPY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 1.88 Billion JPY | -19.559% |
| PRISM BioLab Co.,LTD | 80.3 Million JPY | -2700.867% |
| GNI Group Ltd. | 22.43 Billion JPY | 89.973% |
| Linical Co., Ltd. | 3.77 Billion JPY | 40.469% |
| MEDINET Co., Ltd. | 98.25 Million JPY | -2189.281% |
| Soiken Holdings Inc. | 2.48 Billion JPY | 9.391% |
| Cytori Cell Research Institute, Inc. | 1.29 Billion JPY | -74.009% |
| AnGes, Inc. | -3.06 Billion JPY | 173.379% |
| OncoTherapy Science, Inc. | -177.71 Million JPY | 1365.637% |
| Nxera Pharma Co., Ltd. | 9.66 Billion JPY | 76.725% |
| Immuno-Biological Laboratories Co., Ltd. | 517.29 Million JPY | -334.814% |
| NanoCarrier Co., Ltd. | 110.95 Million JPY | -1927.168% |
| Carna Biosciences, Inc. | 1.45 Billion JPY | -55.058% |
| CanBas Co., Ltd. | -984 Million JPY | 328.584% |
| D. Western Therapeutics Institute, Inc. | 391.69 Million JPY | -474.234% |
| RaQualia Pharma Inc. | 1.65 Billion JPY | -35.813% |
| Chiome Bioscience Inc. | 398.59 Million JPY | -464.298% |
| Kidswell Bio Corporation | 1.03 Billion JPY | -116.404% |
| PeptiDream Inc. | 17.21 Billion JPY | 86.937% |
| Oncolys BioPharma Inc. | 30.6 Million JPY | -7249.335% |
| Ribomic Inc. | -10.5 Million JPY | 21517.482% |
| SanBio Company Limited | -14.5 Million JPY | 15607.887% |
| Healios K.K. | 108 Million JPY | -1982.652% |
| BrightPath Biotherapeutics Co., Ltd. | -341 Thousand JPY | 659708.211% |
| Kubota Pharmaceutical Holdings Co., Ltd. | -59.04 Million JPY | 3909.342% |
| Delta-Fly Pharma, Inc. | -1.51 Million JPY | 148860.847% |
| StemRIM | -44.34 Million JPY | 5171.736% |
| CellSource Co., Ltd. | 3.18 Billion JPY | 29.379% |
| FunPep Company Limited | -680.28 Million JPY | 430.635% |
| Kringle Pharma, Inc. | 69.25 Million JPY | -3148.035% |
| Stella Pharma Corporation | 217.29 Million JPY | -935.106% |
| TMS Co., Ltd. | -6.95 Million JPY | 32463.511% |
| Noile-Immune Biotech Inc. | 314.56 Million JPY | -615.049% |
| Cuorips Inc. | 9.63 Million JPY | -23254.418% |
| K Pharma,Inc. | 910 Million JPY | -147.172% |
| Takara Bio Inc. | 25.45 Billion JPY | 91.164% |
| ReproCELL Incorporated | 1.1 Billion JPY | -103.605% |
| PhoenixBio Co., Ltd. | 1.19 Billion JPY | -88.214% |
| StemCell Institute Inc. | 1.57 Billion JPY | -42.73% |
| Japan Tissue Engineering Co., Ltd. | 1.66 Billion JPY | -34.946% |
| CellSeed Inc. | 107.15 Million JPY | -1999.075% |